DE69732762D1 - Indanderivate für antipsychotische mittel - Google Patents

Indanderivate für antipsychotische mittel

Info

Publication number
DE69732762D1
DE69732762D1 DE69732762T DE69732762T DE69732762D1 DE 69732762 D1 DE69732762 D1 DE 69732762D1 DE 69732762 T DE69732762 T DE 69732762T DE 69732762 T DE69732762 T DE 69732762T DE 69732762 D1 DE69732762 D1 DE 69732762D1
Authority
DE
Germany
Prior art keywords
indanderivates
antipsychotic agents
compounds
provides
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69732762T
Other languages
English (en)
Other versions
DE69732762T2 (de
Inventor
P Hollinshead
E Huff
F Hughes
S Mendoza
H Mitch
A Staszak
S Ward
W Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69732762D1 publication Critical patent/DE69732762D1/de
Publication of DE69732762T2 publication Critical patent/DE69732762T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/12—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DE69732762T 1996-01-22 1997-01-22 Indanderivate für antipsychotische mittel Expired - Fee Related DE69732762T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1028796P 1996-01-22 1996-01-22
US10287P 1996-01-22
PCT/US1997/000997 WO1997025983A1 (en) 1996-01-22 1997-01-22 Indane derivatives for antipsychotic compositions

Publications (2)

Publication Number Publication Date
DE69732762D1 true DE69732762D1 (de) 2005-04-21
DE69732762T2 DE69732762T2 (de) 2006-04-13

Family

ID=21745035

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732762T Expired - Fee Related DE69732762T2 (de) 1996-01-22 1997-01-22 Indanderivate für antipsychotische mittel

Country Status (11)

Country Link
US (1) US6429317B1 (de)
EP (2) EP0880558A1 (de)
JP (2) JP2001521484A (de)
AT (1) ATE290859T1 (de)
AU (2) AU1834997A (de)
CA (2) CA2243717A1 (de)
DE (1) DE69732762T2 (de)
DK (1) DK0874625T3 (de)
ES (1) ES2237788T3 (de)
PT (1) PT874625E (de)
WO (2) WO1997025983A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
JP2001510481A (ja) * 1997-01-22 2001-07-31 イーライ・リリー・アンド・カンパニー インダン様化合物の製造方法
JP2001510797A (ja) 1997-07-22 2001-08-07 イーライ・リリー・アンド・カンパニー 医薬化合物
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
JP2002523451A (ja) 1998-09-01 2002-07-30 ブリストル−マイヤーズ スクイブ カンパニー カリウムチャネル抑制剤および方法
EP1240147A1 (de) 1999-12-21 2002-09-18 Icagen, Inc. Kaliumkanalblocker
US6566380B2 (en) 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6620849B2 (en) 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
IL160751A0 (en) 2001-09-21 2004-08-31 Lilly Co Eli Muscarinic agonists
JP2006521379A (ja) * 2003-03-21 2006-09-21 イーライ リリー アンド カンパニー ムスカリン性アゴニスト
JP2006523223A (ja) * 2003-03-21 2006-10-12 イーライ リリー アンド カンパニー ムスカリン性アゴニスト
JP2007520440A (ja) * 2003-07-03 2007-07-26 イーライ リリー アンド カンパニー ムスカリン性受容体アゴニストとしてのインダン誘導体
SG121940A1 (en) * 2004-10-06 2006-05-26 Shimano Kk Handle knob and handle assembly for a fishing reel
BRPI0516602A (pt) 2004-10-18 2008-09-16 Lilly Co Eli composto, e, composição farmacêutica
CN102918026A (zh) 2010-03-29 2013-02-06 巴斯夫欧洲公司 杀真菌的亚氨基衍生物
EP3610890A1 (de) 2012-11-14 2020-02-19 The Johns Hopkins University Verfahren und zusammensetzungen zur behandlung von schizophrenie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL27999A (en) 1966-05-25 1971-08-25 Egyt Gyogyszervegyeszeti Gyar Naphthyl-and tetrahydronaphthyl-formamidines
JPS6160610A (ja) * 1984-08-31 1986-03-28 Otsuka Pharmaceut Co Ltd 低酸素症改善剤
US4775695A (en) 1987-06-01 1988-10-04 Merck & Co., Inc. Substituted amidinoalkoxy and amidinoalkylamino indanones and salts thereof
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5401848A (en) * 1990-11-26 1995-03-28 E. R. Squibb & Sons, Inc. Indane and quinoline derivatives
US5175166A (en) * 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists
US5446057A (en) * 1993-09-24 1995-08-29 Warner-Lambert Company Substituted tetrahydropyridine and piperidine carboxylic acids as muscarinic antagonists
DE69535315T2 (de) * 1994-01-10 2007-06-28 Teva Pharmaceutical Industries Ltd. 1-aminoindanderivate und zusammensetzungen hiervon
US5712171A (en) 1995-01-20 1998-01-27 Arqule, Inc. Method of generating a plurality of chemical compounds in a spatially arranged array
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
JP2001510481A (ja) * 1997-01-22 2001-07-31 イーライ・リリー・アンド・カンパニー インダン様化合物の製造方法

Also Published As

Publication number Publication date
EP0880558A1 (de) 1998-12-02
JP2001521484A (ja) 2001-11-06
DE69732762T2 (de) 2006-04-13
PT874625E (pt) 2005-07-29
JP2000504320A (ja) 2000-04-11
EP0874625A4 (de) 2001-03-14
AU1582197A (en) 1997-08-11
ES2237788T3 (es) 2005-08-01
WO1997025983A1 (en) 1997-07-24
CA2243500A1 (en) 1997-07-24
CA2243717A1 (en) 1997-07-24
WO1997026300A1 (en) 1997-07-24
EP0874625B1 (de) 2005-03-16
EP0874625A1 (de) 1998-11-04
AU1834997A (en) 1997-08-11
DK0874625T3 (da) 2005-06-20
ATE290859T1 (de) 2005-04-15
US6429317B1 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
ATE290859T1 (de) Indanderivate für antipsychotische mittel
CO4520282A1 (es) Piridinas sustituidas por 2-arilo
DE69943352D1 (de) Azabicycloalkane als ccr5-modulatoren
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
ATE243694T1 (de) 4-mercaptoacetylamino-(2)benzazepinon(3)- derivate, und verwendung als enkephalinase- inhibitoren
YU15299A (sh) Farmaceutski sastavi
BG104247A (en) Resorcinol derivatives
ES2168650T3 (es) Compuestos y metodos moduladores de receptores de androgenos.
BR9808491A (pt) Compostos calcilìticos
PE14199A1 (es) Agonistas de 5-ht1f
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
ATE167670T1 (de) N-alkylthiopolyaminderivate als radioprotektive mittel
EA199900362A1 (ru) Новые соединения, полезные для использования в качестве нейрозащитных средств
BR9708347A (pt) Compostos de tetrahidorbeta-carbonila
DE69727312D1 (de) 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals
PT882726E (pt) Carbazol-carboxamidas como agonistas 5-ht1f
DE69501086T2 (de) Graphitstahlzusammensetzungen
DE69709902D1 (de) Halbes packungsstück fur kabeldurchfuhrung
DE69900281T2 (de) Oxidationsfärbungszusammensetzung für keratinische Fäser und Färbungsverfahren mit derselben
PL331882A1 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofurane amines and 2-amino cyclohepta[b]benzofuranes
MX9500228A (es) N-oxidos de 4-arilpiperazinas y 4-arilpiperidinas.
ATA172897A (de) Reaktionstiegel für eine aluminothermische schienenschweissvorrichtung
SE8502865D0 (sv) Naphtoxazine, ihre herstellung und verwendung
ATE216450T1 (de) Ausgleichringe für schachtabdeckungen und strasseneinläufe
HN1998000197A (es) Compuestos de indol 2,3 sustituidas como agentes antiinflamatorios y analgesiscos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee